{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T18:17:12Z","timestamp":1766600232906,"version":"3.37.3"},"reference-count":53,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.numecd.2016.08.004","type":"journal-article","created":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T08:45:43Z","timestamp":1471941943000},"page":"1129-1139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications"],"prefix":"10.1016","volume":"26","author":[{"given":"S.","family":"Di Mauro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ragusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Urbano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Filippello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Di Pino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Scamporrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pulvirenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Rabuazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8873-3660","authenticated-orcid":false,"given":"M.","family":"Purrello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Purrello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Piro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2016.08.004_bib1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2036.2010.04556.x","article-title":"Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"33","author":"Dowman","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.numecd.2016.08.004_bib2","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","article-title":"Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference","volume":"37","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2016.08.004_bib3","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/hep.21768","article-title":"Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future","volume":"46","author":"Wieckowska","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2016.08.004_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-0034-1397345","article-title":"MicroRNAs in fatty liver disease","volume":"35","author":"Sobolewski","year":"2015","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.numecd.2016.08.004_bib5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1101\/sqb.2011.76.011049","article-title":"MicroRNAs in metabolism and metabolic diseases","volume":"76","author":"Rottiers","year":"2011","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1016\/j.numecd.2016.08.004_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/2211536611302010007","article-title":"Circulating microRNAs as biomarkers for inflammatory diseases","volume":"2","author":"Mi","year":"2013","journal-title":"Microrna"},{"key":"10.1016\/j.numecd.2016.08.004_bib7","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.3748\/wjg.v17.i19.2379","article-title":"Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells","volume":"17","author":"Chu","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.numecd.2016.08.004_bib8","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00394-012-0467-5","article-title":"Inhibition of DNA-dependent protein kinase reduced palmitate and oleate-induced lipid accumulation in HepG2 cells","volume":"52","author":"Kwan","year":"2013","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.numecd.2016.08.004_bib9","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1440-1746.2008.05733.x","article-title":"Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes","volume":"24","author":"Ricchi","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2016.08.004_bib10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cbi.2006.11.004","article-title":"A human hepatocellular in vitro model to investigate steatosis","volume":"165","author":"Gomez-Lechon","year":"2007","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.numecd.2016.08.004_bib11","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jhep.2010.01.003","article-title":"Palmitoleate attenuates palmitate-induced Bim and PUMA upregulation and hepatocyte lipoapoptosis","volume":"52","author":"Akazawa","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2016.08.004_bib12","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.9788","article-title":"Post-transcriptional knowledge in pathway analysis increases the accuracy of phenotypes classification","author":"Alaimo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.numecd.2016.08.004_bib13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.18632\/oncoscience.19","article-title":"Highly skewed distribution of miRNAs and proteins between colorectal cancer cells and their exosomes following Cetuximab treatment: biomolecular, genetic and translational implications","volume":"1","author":"Ragusa","year":"2014","journal-title":"Oncoscience"},{"key":"10.1016\/j.numecd.2016.08.004_bib14","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1083\/jcb.100.3.965","article-title":"Nile red: a selective fluorescent stain for intracellular lipid droplets","volume":"100","author":"Greenspan","year":"1985","journal-title":"J Cell Biol"},{"key":"10.1016\/j.numecd.2016.08.004_bib15","first-page":"284","article-title":"Lipotoxicity in HepG2 cells triggered by free fatty acids","volume":"3","author":"Yao","year":"2011","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.numecd.2016.08.004_bib16","doi-asserted-by":"crossref","first-page":"C558","DOI":"10.1152\/ajpcell.00148.2015","article-title":"Altered expression of uncoupling protein 2 in GLP-1-producing cells after chronic high glucose exposure: implications for the pathogenesis of diabetes mellitus","volume":"310","author":"Urbano","year":"2016","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.numecd.2016.08.004_bib17","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1210\/en.2009-1472","article-title":"Palmitate affects insulin receptor phosphorylation and intracellular insulin signal in a pancreatic alpha-cell line","volume":"151","author":"Piro","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.numecd.2016.08.004_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090093","article-title":"Chronic exposure to GLP-1 increases GLP-1 synthesis and release in a pancreatic alpha cell line (alpha-TC1): evidence of a direct effect of GLP-1 on pancreatic alpha cells","volume":"9","author":"Piro","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.numecd.2016.08.004_bib19","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fncel.2014.00156","article-title":"Identification of circulating microRNAs for the differential diagnosis of Parkinson\u2019s disease and multiple system atrophy","volume":"8","author":"Vallelunga","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.numecd.2016.08.004_bib20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1471-2164-14-62","article-title":"miR-296-3p, miR-298-5p and their downstream networks are causally involved in the higher resistance of mammalian pancreatic alpha cells to cytokine-induced apoptosis as compared to beta cells","volume":"14","author":"Barbagallo","year":"2013","journal-title":"BMC Genomics"},{"key":"10.1016\/j.numecd.2016.08.004_bib21","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1080\/15384047.2015.1046021","article-title":"miRNA profiling in vitreous humor, vitreal exosomes and serum from uveal melanoma patients: pathological and diagnostic implications","volume":"16","author":"Ragusa","year":"2015","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.numecd.2016.08.004_bib22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1053\/j.gastro.2007.11.037","article-title":"Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis","volume":"134","author":"Zhou","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.numecd.2016.08.004_bib23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cmet.2012.04.002","article-title":"A ceramide-centric view of insulin resistance","volume":"15","author":"Chavez","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.numecd.2016.08.004_bib24","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/en.2015-1866","article-title":"Hepatocyte- specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-fed mice","volume":"157","author":"Wilson","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.numecd.2016.08.004_bib25","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3945\/an.113.004648","article-title":"Hepatic fatty acid trafficking: multiple forks in the road","volume":"4","author":"Mashek","year":"2013","journal-title":"Adv Nutr"},{"key":"10.1016\/j.numecd.2016.08.004_bib26","doi-asserted-by":"crossref","first-page":"10851","DOI":"10.3748\/wjg.v20.i31.10851","article-title":"Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future","volume":"20","author":"Fitzpatrick","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.numecd.2016.08.004_bib27","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.orcp.2015.01.006","article-title":"Circulating microRNA-223 as a potential biomarker for obesity","volume":"9","author":"Wen","year":"2015","journal-title":"Obes Res Clin Pract"},{"key":"10.1016\/j.numecd.2016.08.004_bib28","doi-asserted-by":"crossref","first-page":"14518","DOI":"10.1073\/pnas.1215767111","article-title":"MicroRNA-223 coordinates cholesterol homeostasis","volume":"111","author":"Vickers","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.numecd.2016.08.004_bib29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1477-9560-10-16","article-title":"Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol","volume":"10","author":"Sun","year":"2012","journal-title":"Thromb J"},{"key":"10.1016\/j.numecd.2016.08.004_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128140","article-title":"Micro-RNAs Let7e and 126 in plasma as markers of metabolic dysfunction in 10 to 12 years old children","volume":"10","author":"Krause","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.numecd.2016.08.004_bib31","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/CIRCRESAHA.110.226357","article-title":"Plasma VmicroRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes","volume":"107","author":"Zampetaki","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.numecd.2016.08.004_bib32","doi-asserted-by":"crossref","first-page":"E2271","DOI":"10.1210\/jc.2012-1996","article-title":"Circulating miRNA profiles in patients with metabolic syndrome","volume":"97","author":"Karolina","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2016.08.004_bib33","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins","volume":"13","author":"Vickers","year":"2011","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.numecd.2016.08.004_bib34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/CIRCRESAHA.114.300645","article-title":"MicroRNA control of high-density lipoprotein metabolism and function","volume":"114","author":"Rayner","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.numecd.2016.08.004_bib35","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/ATVBAHA.112.300741","article-title":"Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs","volume":"33","author":"Wagner","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2016.08.004_bib36","doi-asserted-by":"crossref","first-page":"e105192","DOI":"10.1371\/journal.pone.0105192","article-title":"A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease","volume":"9","author":"Tan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.numecd.2016.08.004_bib37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cell.2011.08.033","article-title":"The Lin28\/let-7 axis regulates glucose metabolism","volume":"147","author":"Zhu","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.numecd.2016.08.004_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089446","article-title":"Up-regulation of microRNA-190b plays a role for decreased IGF-1 that induces insulin resistance in human hepatocellular carcinoma","volume":"9","author":"Hung","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.numecd.2016.08.004_bib39","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1128\/MCB.01714-12","article-title":"A regulatory role for microRNA 33* in controlling lipid metabolism gene expression","volume":"33","author":"Goedeke","year":"2013","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.numecd.2016.08.004_bib40","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00125-013-2950-9","article-title":"Human adipose microRNA-221 is upregulated in obesity and affects fat metabolism downstream of leptin and TNF-alpha","volume":"56","author":"Meerson","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2016.08.004_bib41","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/scd.2010.0072","article-title":"MicroRNA hsa-miR-138 inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells through adenovirus EID-1","volume":"20","author":"Yang","year":"2011","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.numecd.2016.08.004_bib42","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/cdd.2011.183","article-title":"Programming of adipose tissue miR-483-3p and GDF-3 expression by maternal diet in type 2 diabetes","volume":"19","author":"Ferland-McCollough","year":"2012","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.numecd.2016.08.004_bib43","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/hep.22569","article-title":"Nonalcoholic steatohepatitis is associated with altered hepatic Micro-RNA expression","volume":"48","author":"Cheung","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2016.08.004_bib44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200422422","article-title":"Molecular mediators of hepatic steatosis and liver injury","volume":"114","author":"Browning","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.numecd.2016.08.004_bib45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5009\/gnl.2012.6.2.149","article-title":"NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications","volume":"6","author":"Farrell","year":"2012","journal-title":"Gut Liver"},{"key":"10.1016\/j.numecd.2016.08.004_bib46","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/hep.27695","article-title":"Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids","volume":"61","author":"Arendt","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2016.08.004_bib47","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.23941","article-title":"Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice","volume":"52","author":"Gupte","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2016.08.004_bib48","first-page":"351","article-title":"Reevaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease","volume":"20","author":"Kohjima","year":"2007","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.numecd.2016.08.004_bib49","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1177\/147323001103900410","article-title":"The role of hepatic liver X receptor alpha- and sterol regulatory element binding protein-1c-mediated lipid disorder in the pathogenesis of nonalcoholic steatohepatitis in rats","volume":"39","author":"Ai","year":"2011","journal-title":"J Int Med Res"},{"key":"10.1016\/j.numecd.2016.08.004_bib50","first-page":"505","article-title":"Expression of fatty acid synthase in nonalcoholic fatty liver disease","volume":"3","author":"Dorn","year":"2010","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.numecd.2016.08.004_bib51","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/hep.26052","article-title":"Solute carrier family 2 member 1 is involved in the development of nonalcoholic fatty liver disease","volume":"57","author":"Vazquez-Chantada","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2016.08.004_bib52","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbacli.2015.02.001","article-title":"Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy","volume":"3","author":"Nagaya","year":"2015","journal-title":"BBA Clin"},{"key":"10.1016\/j.numecd.2016.08.004_bib53","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7150\/ijms.13581","article-title":"Palmitate-induced regulation of PPARgamma via PGC1alpha: a mechanism for lipid accumulation in the liver in nonalcoholic fatty liver disease","volume":"13","author":"Maruyama","year":"2016","journal-title":"Int J Med Sci"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475316301375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475316301375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T12:09:47Z","timestamp":1656936587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475316301375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":53,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0939475316301375"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2016.08.004","relation":{},"ISSN":["0939-4753"],"issn-type":[{"type":"print","value":"0939-4753"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2016.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}